Amalgamated Bank lessened its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Get Rating) by 4.5% in the 1st quarter, Holdings Channel reports. The firm owned 56,529 shares of the company’s stock after selling 2,654 shares during the period. Amalgamated Bank’s holdings in HealthEquity were worth $3,812,000 at the end of the most recent reporting period.
Several other hedge funds have also recently modified their holdings of HQY. Veritable L.P. purchased a new stake in HealthEquity during the 1st quarter valued at about $242,000. HighTower Advisors LLC grew its stake in HealthEquity by 1.3% during the 1st quarter. HighTower Advisors LLC now owns 82,558 shares of the company’s stock valued at $5,569,000 after acquiring an additional 1,029 shares in the last quarter. Woodline Partners LP grew its stake in HealthEquity by 201.9% during the 1st quarter. Woodline Partners LP now owns 190,180 shares of the company’s stock valued at $12,826,000 after acquiring an additional 127,188 shares in the last quarter. Inspire Investing LLC purchased a new stake in HealthEquity during the 1st quarter valued at about $233,000. Finally, Fifth Third Bancorp grew its stake in HealthEquity by 15.0% during the 1st quarter. Fifth Third Bancorp now owns 10,297 shares of the company’s stock valued at $694,000 after acquiring an additional 1,343 shares in the last quarter. Institutional investors and hedge funds own 99.43% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on HQY shares. The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Tuesday, July 12th. They set a “sell” rating and a $59.00 price objective for the company. Barrington Research increased their price target on shares of HealthEquity from $70.00 to $75.00 in a research note on Tuesday, June 7th. Robert W. Baird increased their price target on shares of HealthEquity from $47.00 to $67.00 and gave the company a “neutral” rating in a research note on Wednesday, September 7th. KeyCorp began coverage on shares of HealthEquity in a research note on Thursday, September 15th. They issued an “overweight” rating and a $85.00 price target for the company. Finally, Raymond James increased their price target on shares of HealthEquity from $70.00 to $75.00 and gave the company an “outperform” rating in a research note on Monday, September 12th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $75.36.
Insiders Place Their Bets
HealthEquity Stock Performance
NASDAQ:HQY opened at $71.85 on Thursday. The stock has a market capitalization of $6.07 billion, a P/E ratio of -97.09, a PEG ratio of 4.27 and a beta of 0.90. The company has a 50 day moving average price of $62.70 and a 200 day moving average price of $62.64. HealthEquity, Inc. has a fifty-two week low of $36.81 and a fifty-two week high of $73.54.
HealthEquity (NASDAQ:HQY – Get Rating) last posted its quarterly earnings data on Tuesday, September 6th. The company reported $0.33 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same quarter in the previous year, the company posted $0.21 earnings per share. Research analysts forecast that HealthEquity, Inc. will post 0.69 earnings per share for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
- Get a free copy of the StockNews.com research report on HealthEquity (HQY)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- General Mills: Superior Returns With Less Volatility
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.